Brachytherapy Market to Reach US$ 1.5 Billion by 2031 at 8.1% CAGR, Driven by Rising Cancer Incidence and Minimally Invasive Treatment Preference | DataM Intelligence

According to DataM Intelligence, the global Brachytherapy market reached US$ 0.8 billion in 2022 and is expected to reach US$ 1.5 billion by 2031, growing at a CAGR of 8.1% during the forecast period 2024-2031, driven by increasing prevalence of prostate, gynecological, and breast cancers, strong adoption of high-dose and low-dose brachytherapy, growing preference for targeted radiation with fewer side effects, expanding ambulatory surgery centers.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/brachytherap-market?jd

United States Key Industry Developments

☑️ January 2026: Perspective Therapeutics expanded U.S. brachytherapy device availability with new high-dose systems for prostate and gynecological cancers, securing additional hospital contracts.
☑️ January 2026: Varian Medical Systems, Inc. reported strong growth in its brachytherapy portfolio, launching upgraded applicators and planning software for precise dose delivery in breast cancer treatment.
☑️ December 2025: Elekta AB advanced its brachytherapy solutions with enhanced imaging integration, gaining wider adoption in U.S. ambulatory surgery centers for outpatient procedures.

Japan Key Industry Developments

☑️ January 2026: Japanese oncology centers accelerated adoption of high-dose brachytherapy for prostate and gynecological cancers, supported by updated national cancer treatment guidelines.
☑️ January 2026: Local and global players showcased advanced brachytherapy applicators and planning systems at major Tokyo radiation oncology conferences, focusing on precision and patient safety.
☑️ December 2025: Growing integration of brachytherapy in Japan's hospitals and specialized clinics, driven by demand for minimally invasive options in breast and prostate cancer management.

Key Mergers and Acquisitions

✦ January 2026: Varian Medical Systems, Inc. acquired a brachytherapy applicator technology startup to enhance its portfolio for gynecological and breast cancer applications.
✦ December 2025: Elekta AB completed a strategic acquisition of a radiation planning software firm to strengthen its brachytherapy treatment planning capabilities.
✦ November 2025: Perspective Therapeutics secured a licensing agreement with an advanced seed implant innovator to expand its low-dose brachytherapy offerings for prostate cancer.

Purchase the report to unlock market insights:
https://www.datamintelligence.com/buy-now-page?report=brachytherap-market

Market Segmentation Analysis

By Therapy Type: High Dose Brachytherapy holds the largest share due to precise dose delivery and shorter treatment times in prostate, gynecological, and breast cancers; Low Dose Brachytherapy grows steadily for permanent seed implants in prostate cancer.

By Application Type: Prostate Cancer dominates with the highest share driven by established low-dose seed implantation; Gynecological Cancer and Breast Cancer follow for high-dose applications; Others include head & neck, lung, and soft tissue sarcomas.

By End-User: Hospitals lead with major share for complex procedures and high-dose treatments; Ambulatory Surgery Centers (ASCs) grow rapidly for minimally invasive low-dose and outpatient high-dose cases; Others include specialty oncology clinics and research centers.

Regional Insights

North America commands the largest market share in the global Brachytherapy market, supported by high cancer incidence, advanced radiation oncology infrastructure, rapid adoption of high-dose and low-dose techniques, strong reimbursement for brachytherapy procedures, and presence of leading device manufacturers driving innovation in applicators and planning systems.
Asia-Pacific remains the fastest-growing region, fueled by rising cancer burden, increasing healthcare investments in China, India, and Japan, expanding oncology centers and ambulatory facilities, growing awareness of targeted radiation therapies, and aggressive market entry by global and local players focusing on cost-effective solutions.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/brachytherap-market?jd

Key Players

The market includes leading companies such as Perspective Therapeutics, Theragenics, Eckert & Ziegler, Civco Medical Solutions, Mirion Technologies, Elekta AB, IsoAid, Varian Medical Systems, Inc., Prowess Inc., RaySearch Laboratories, and others.

Key Highlights (Top 5 Key Players)

✦ Varian Medical Systems, Inc. - Leading provider of brachytherapy solutions with advanced applicators, planning software, and high-dose systems, dominant in prostate and gynecological cancer treatments.
✦ Elekta AB - Renowned for comprehensive brachytherapy platforms, emphasizing precision delivery and integration with imaging for improved patient outcomes.
✦ Eckert & Ziegler - Strong in low-dose seed implants and high-dose afterloaders, with wide adoption in prostate brachytherapy and global reach.
✦ Theragenics - Specialized in low-dose brachytherapy seeds and devices, focusing on prostate cancer with high-quality and reliable products.
✦ IsoAid - Key player in low-dose seed implantation, providing cost-effective and customizable solutions for prostate brachytherapy.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd

Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.